• English
    • français
  • Help
  •  | 
  • Contact
  •  | 
  • About
  •  | 
  • Login
  • HAL portal
  •  | 
  • Pages Pro
  • EN
  •  / 
  • FR
View Item 
  •   LillOA Home
  • Liste des unités
  • Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
  • View Item
  •   LillOA Home
  • Liste des unités
  • Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Macromolecular synthesis inhibitors perturb ...
  • BibTeX
  • CSV
  • Excel
  • RIS

Document type :
Article dans une revue scientifique
DOI :
10.1016/j.jsbmb.2011.04.008
PMID :
21569845
Permalink :
http://hdl.handle.net/20.500.12210/11233
Title :
Macromolecular synthesis inhibitors perturb glucocorticoid receptor trafficking
Author(s) :
Dezitter, Xavier [Auteur]
Masselot, Bernadette [Auteur]
Tardivel, Meryem [Auteur]
Mereau-Richard, Claude [Auteur]
Formstecher, Pierre [Auteur]
Idziorek, Thierry [Auteur]
Journal title :
The Journal of steroid biochemistry and molecular biology
Abbreviated title :
J. Steroid Biochem. Mol. Biol.
Volume number :
126
Pages :
104-112
Publication date :
2011-09-01
ISSN :
0960-0760
English keyword(s) :
Inhibitors
Thymocytes
Apoptosis
Glucocorticoids
Translation
Transcription
Cycloheximide
Actinomycin D
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
The ability of inhibitors of transcription and translation to prevent glucocorticoid-induced apoptosis has been interpreted to indicate that the cell death machinery requires de novo protein synthesis. The transcriptional ...
Show more >
The ability of inhibitors of transcription and translation to prevent glucocorticoid-induced apoptosis has been interpreted to indicate that the cell death machinery requires de novo protein synthesis. The transcriptional inhibitors actinomycin D (Act D) and DRB as well as the translational inhibitors CHX and puromycin inhibited early loss of mitochondrial membrane integrity in a dose-dependent manner. This effect was not observed with the transcriptional inhibitor α-amanitin suggesting they may have additional effects. Their role in the glucocorticoid receptor (GR) intracellular trafficking was therefore investigated. Here, we show that Act D and CHX reduced glucocorticoid binding, GR turnover and impaired GR nuclear translocation. We performed the same experiments in different thymocyte subpopulations of Balb/c mice. At the highest dose tested, actinomycin D and cycloheximide abolished glucocorticoid-induced cell death of CD4+CD8+ and CD4+CD8-. In all subsets, Act D, DRB, as well as CHX and puromycin prevented receptor nuclear translocation, indicating a general alteration of GR trafficking. Overall, our data support a direct effect of macromolecular inhibitors on GR activation and trafficking. Finally, direct alterations of the functional properties of the glucocorticoid receptor might be responsible for cell death prevention by actinomycin D, DRB, cycloheximide and puromycin.Show less >
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
CHU Lille
Inserm
Université de Lille
Collections :
  • Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
  • Lille Neurosciences & Cognition (LilNCog) - U 1172
Research team(s) :
Therapeutic innovation targetting inflammation
Submission date :
2019-05-17T13:08:46Z
Université de Lille

Mentions légales
Université de Lille © 2017